Regencell Bioscience HoldingsRGC 
$6.611.54%24h
1.54%24h
Global rank22068
Market cap$86.02M
Change 7d-
YTD Performance-37.05%
SP500 benchmarkUnderperform
P/E-14.69
P/S0
Revenue$0
Earnings-$6.06M
Dividend yield-
Main Sector
Healthcare
Category
EPS for Regencell Bioscience Holdings (RGC)
Regencell Bioscience Holdings has an EPS of $-0.45. In 2022, the company made an earnings per share (EPS) of $-0.58. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for RGC
-
Value:-
EPS history for Regencell Bioscience Holdings from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | -$0.45 | -22.41% |
| 2022 | -$0.58 | 444.45% |
| 2021 | -$0.106529 | 65.78% |
| 2020 | -$0.064259 | - |
View the highest EPS stocks
